Foxx Life Sciences concludes Open House Event
Thomas Taylor, Founder and CEO, Foxx Life Sciences, during the Open house event, in Hyderabad

Hyderabad: Foxx Life Sciences, a custom bioprocessing solution provider, on Friday announced the comple-tion of its Open House event, held at the company's facility in the city. During the event, Indus-try leaders, partners, and community members interacted with the company’s experts to explore the latest advancements in manufacturing, and discover Foxx Life Sciences’ solutions.
“We are excited with the turnout and positive feedback from our Open House event. This event underscores our dedication to fostering innovation and collaboration in India within the life sciences community,” said Thomas Taylor, Founder and CEO of Foxx Life Sciences.
He further informed that Foxx Life Sciences has completed five years of Bioprocess manufacturing in India. The company has two manufacturing plants, including a state-of-the-art blow and injection molding facility, which is spread across 40,000 sft.
Eknath Kulkarni, Co-Founder and President, Foxx Life Sciences APAC, said: “We will continue to building strong relationships with our customers, suppliers, and employees with these new major investments. From R&D, prototyping, machining, welding, injection molding, clean room assembly, and Asia logistics, Foxx is ready to support our global customers.”
Rick Schwartz, President, Foxx Life Sciences, added, “The Open House was an opportunity to showcase our capabilities and share our vision for the future. We are committed to driving growth and excellence in the industry, and events like this help us connect with the community and highlight our contributions.”